{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie7gocrflzlayunqc4xljwdfw4qqzjfygk5jb2ed2a3twxuhymnhi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mk774eqg6752"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibvtdhjfghbjqwojaki2lv24lso6lb3eauroafksjpgw4bxhunpni"
    },
    "mimeType": "image/jpeg",
    "size": 751867
  },
  "path": "/news/2026-04-ai-individual-breast-cells-cancer.html",
  "publishedAt": "2026-04-23T19:30:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women's breast cancer risk at the cellular level. The first-of-its-kind platform squeezes individual breast epithelial cells, creating a taxing environment to measure how they deform, recover, and behave under stress, according to a new study published in eBioMedicine.",
  "title": "AI squeezes individual breast cells to learn how to spot cancer risk"
}